Exploring the biology of vascular calcification in chronic kidney disease: what's circulating?

M Schoppet1, R C Shroff, L C Hofbauer

  • 1Division of Cardiovascular Medicine, Addenbrooke's Hospital, Cambridge, UK.

Kidney International
|November 30, 2007
PubMed

Insights

Chronic kidney disease (CKD) accelerates vascular calcification by overwhelming inhibitors, damaging vascular cells, and altering mineral balance. Understanding circulating inhibitors may offer new strategies to prevent calcifying vasculopathies in CKD patients.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Biochemistry

Background:

  • Chronic kidney disease (CKD) is linked to severe cardiovascular issues, primarily due to ectopic calcification in arteries, capillaries, and heart valves.
  • Vascular calcification in CKD is a multifactorial process involving mineral imbalances (hyperphosphatemia, high calcium x phosphate product), deficient calcification inhibitors, vascular smooth muscle cell (VSMC) damage, and VSMC phenotypic transformation.

Purpose of the Study:

  • To investigate the role of calcification inhibitors in CKD-associated vascular calcification.
  • To explore the mechanisms and sites of action for identified calcification inhibitors.
  • To determine if circulating inhibitors influence disease progression or indicate underlying pathologies in CKD patients.

Main Methods:

  • Analysis of experimental studies and in vivo data.
  • Studies involving genetically altered mice to identify calcification inhibitors.
  • Investigation into the mechanisms of VSMC damage and cell death in CKD.

Main Results:

  • CKD patients exhibit overwhelmed inhibitory systems, leading to VSMC damage and cell death.
  • Vesicles released from damaged cells can nucleate basic calcium phosphate, promoting calcification.
  • Genetically modified mouse models have identified local and systemic calcification inhibitors crucial for VSMC differentiation and vesicle regulation.

Conclusions:

  • A deeper understanding of circulating calcification inhibitors' origins and functions is crucial.
  • Identifying the roles of these inhibitors could lead to novel therapeutic strategies for CKD-related calcifying vasculopathies.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...